You need JavaScript to view this

Investigations of relevance of the tumor marker neopterine for therapeutic decision and control of progress in mammary carcinoma. Untersuchungen zur Relevanz des Tumormarkers Neopterin fuer die Therapieentscheidung und Verlaufskontrolle bei Mammakarzinom

Journal Article:

Abstract

The value of serum neopterin as tumor marker was verified in 104 breast cancer patients. Based on the results the evaluation of neopterin cannot be recommended, neither for the decision of treatment after primary therapy nor for monitoring of the breast cancer. (author).
Authors:
Hacker, I; Lauterbach, H; Kob, D [1] 
  1. Jena Univ. (German Democratic Republic). Radiologische Klinik und Poliklinik
Publication Date:
Jan 01, 1989
Product Type:
Journal Article
Reference Number:
AIX-21-014521; EDB-90-029046
Resource Relation:
Journal Name: Radiobiologia, Radiotherapia; (German Democratic Republic); Journal Volume: 30:6
Subject:
62 RADIOLOGY AND NUCLEAR MEDICINE; RADIOTHERAPY; PTERIDINES; BLOOD SERUM; CARCINOMAS; MAMMARY GLANDS; PATIENTS; AROMATICS; AZAARENES; BODY; DISEASES; GLANDS; HETEROCYCLIC COMPOUNDS; MEDICINE; NEOPLASMS; NUCLEAR MEDICINE; ORGANIC COMPOUNDS; ORGANIC NITROGEN COMPOUNDS; ORGANS; RADIOLOGY; THERAPY; 550603* - Medicine- External Radiation in Therapy- (1980-)
OSTI ID:
5026707
Country of Origin:
Germany
Language:
German
Other Identifying Numbers:
Journal ID: ISSN 0033-8184; CODEN: RDBGA
Submitting Site:
INIS
Size:
Pages: 519-524
Announcement Date:
Feb 15, 1990

Journal Article:

Citation Formats

Hacker, I, Lauterbach, H, and Kob, D. Investigations of relevance of the tumor marker neopterine for therapeutic decision and control of progress in mammary carcinoma. Untersuchungen zur Relevanz des Tumormarkers Neopterin fuer die Therapieentscheidung und Verlaufskontrolle bei Mammakarzinom. Germany: N. p., 1989. Web.
Hacker, I, Lauterbach, H, & Kob, D. Investigations of relevance of the tumor marker neopterine for therapeutic decision and control of progress in mammary carcinoma. Untersuchungen zur Relevanz des Tumormarkers Neopterin fuer die Therapieentscheidung und Verlaufskontrolle bei Mammakarzinom. Germany.
Hacker, I, Lauterbach, H, and Kob, D. 1989. "Investigations of relevance of the tumor marker neopterine for therapeutic decision and control of progress in mammary carcinoma. Untersuchungen zur Relevanz des Tumormarkers Neopterin fuer die Therapieentscheidung und Verlaufskontrolle bei Mammakarzinom." Germany.
@misc{etde_5026707,
title = {Investigations of relevance of the tumor marker neopterine for therapeutic decision and control of progress in mammary carcinoma. Untersuchungen zur Relevanz des Tumormarkers Neopterin fuer die Therapieentscheidung und Verlaufskontrolle bei Mammakarzinom}
author = {Hacker, I, Lauterbach, H, and Kob, D}
abstractNote = {The value of serum neopterin as tumor marker was verified in 104 breast cancer patients. Based on the results the evaluation of neopterin cannot be recommended, neither for the decision of treatment after primary therapy nor for monitoring of the breast cancer. (author).}
journal = {Radiobiologia, Radiotherapia; (German Democratic Republic)}
volume = {30:6}
journal type = {AC}
place = {Germany}
year = {1989}
month = {Jan}
}